Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Central Government To Allocate RMB 2.7 Billion For Health Care Facilities In Rural Areas

This article was originally published in PharmAsia News

Executive Summary

The Ministry of Heath has revealed details for 2009's centralized purchasing of medical devices. The central government's almost RMB 2.7 billion funds ($392.9 million) for rural health care infrastructure on the level of county, village and hamlet will mainly be used for medical facilities and equipment. Besides continuing to provide basic health infrastructure for towns, the government will equip women's and children's health care organizations as well as TCM hospitals in the county. According to the "Program for Establishing and Developing a Rural Health Care Service System," the government will allocate an average of RMB 80,000 for general clinics, RMB 20,000 for central clinics, RMB 25,000 and RMB 380,000 for women's and children's health care centers and institutions respectively, and RMB 1 million for TCM hospitals. (Click here for more - Chinese Language)

You may also be interested in...



Increased Competition For Medical Devices Drives Profits Down For Shanghai Medical

SHANGHAI - Increased competition and pricing pressures for medical devices led to lower profits for Shanghai Medical Technology's second quarter ended June 30, the company announced Aug. 21

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 

UsernamePublicRestriction

Register

LL1134025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel